Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H14N2O6 |
| Molecular Weight | 258.228 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)NC1=O
InChI
InChIKey=DWRXFEITVBNRMK-JAGXHNFQSA-N
InChI=1S/C10H14N2O6/c1-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)18-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7+,9-/m1/s1
| Molecular Formula | C10H14N2O6 |
| Molecular Weight | 258.228 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. | 2010-10 |
|
| Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA. | 2009-09-10 |
|
| Substrate specificity of feline and canine herpesvirus thymidine kinase. | 2008-08 |
|
| Efficient and selective enzymatic acylation reaction: separation of furanosyl and pyranosyl nucleosides. | 2008-07-18 |
|
| Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. | 2008 |
|
| N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors. | 2006-12-28 |
|
| Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts. | 2006-05-26 |
|
| 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods. | 2006-02-15 |
|
| The effect of a methyl or 2-fluoroethyl substituent at the N-3 position of thymidine, 3'-fluoro-3'-deoxythymidine and 1-beta-D-arabinosylthymine on their antiviral and cytostatic activity in cell culture. | 2006 |
|
| Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides. | 2005-12-15 |
|
| Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster. | 2005-08 |
|
| Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. | 2005-04-02 |
|
| Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. | 2004-03-19 |
|
| Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides. | 2004 |
|
| Lipid-mediated protein delivery of suicide nucleoside kinases. | 2003-10-15 |
|
| Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. | 2003-09-15 |
|
| Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents. | 2003-02 |
|
| Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol. | 2001-11-23 |
|
| Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors. | 2001-05-21 |
|
| 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase. | 2001-03-15 |
|
| Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase. | 2001-02 |
|
| Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. | 1999-10 |
|
| Efficacy of select antivirals against Cryptosporidium parvum in vitro. | 1998-11-01 |
|
| Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus. | 1998-08 |
|
| Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus. | 1997-08 |
|
| Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds. | 1995-07 |
|
| Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. | 1995-04 |
|
| Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides. | 1989-02 |
|
| Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. | 1988-07 |
|
| 7-Aminoquinolines. A novel class of agents active against herpesviruses. | 1988-07 |
|
| Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs. | 1986-03 |
|
| Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. | 1986-03 |
|
| In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds. | 1984-06 |
|
| Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines. | 1983-09 |
|
| Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate. | 1982-09 |
|
| Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus. | 1982-02 |
|
| In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. | 1982-01 |
|
| Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. | 1981-09 |
|
| Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils. | 1981-07 |
|
| Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil. | 1980-06 |
|
| Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice. | 1979-11 |
|
| In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil. | 1979-08 |
|
| (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. | 1979-06 |
|
| Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. | 1979-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:09:51 GMT 2025
by
admin
on
Mon Mar 31 22:09:51 GMT 2025
|
| Record UNII |
NS9U4BEG7Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
68929
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY | |||
|
NS9U4BEG7Y
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY | |||
|
65049
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY | |||
|
605-23-2
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY | |||
|
210-083-7
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY | |||
|
DTXSID201194189
Created by
admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |